tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

VACC

Vaccitech renames as Barinthus Biotherapeutics, announces presentations
The FlyVaccitech renames as Barinthus Biotherapeutics, announces presentations
6M ago
VACC
Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer
PremiumPress Releases
Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer
6M ago
VACC
Vaccitech initiated with a Buy at Alliance Global Partners
PremiumThe Fly
Vaccitech initiated with a Buy at Alliance Global Partners
7M ago
VACC
Vaccitech downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe Fly
Vaccitech downgraded to Equal Weight from Overweight at Morgan Stanley
7M ago
VACC
Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023
PremiumPress Releases
Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023
7M ago
VACC
Vaccitech announces upcoming milestones
PremiumThe FlyVaccitech announces upcoming milestones
9M ago
VACC
Vaccitech reports Q2 EPS (62c), consensus (55c)
PremiumThe Fly
Vaccitech reports Q2 EPS (62c), consensus (55c)
9M ago
VACC
Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
PremiumPress Releases
Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
9M ago
VACC
Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
PremiumPress Releases
Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
10M ago
VACC
Vaccitech doses first patient in PCA001 Phase 1/2 trial of VTP-850
PremiumThe Fly
Vaccitech doses first patient in PCA001 Phase 1/2 trial of VTP-850
11M ago
VACC
Vaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local Therapy
PremiumPress Releases
Vaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local Therapy
11M ago
VACC
Vaccitech Reports First Quarter 2023 Financial Results and Recent Corporate Developments
PremiumPress Releases
Vaccitech Reports First Quarter 2023 Financial Results and Recent Corporate Developments
12M ago
VACC
Vaccitech presents interim data from Phase 1b/2 study of VTP-200
PremiumThe FlyVaccitech presents interim data from Phase 1b/2 study of VTP-200
1y ago
VACC
Vaccitech : Phase 1b/2a trial of VTP-300 met primary, secondary endpoints
PremiumThe Fly
Vaccitech : Phase 1b/2a trial of VTP-300 met primary, secondary endpoints
1y ago
VACC
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
PremiumPress Releases
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
1y ago
VACC
Vaccitech price target lowered to $15 from $20 at H.C. Wainwright
PremiumThe Fly
Vaccitech price target lowered to $15 from $20 at H.C. Wainwright
1y ago
VACC
Vaccitech price target lowered to $7 from $23 at Barclays
PremiumThe Fly
Vaccitech price target lowered to $7 from $23 at Barclays
1y ago
VACC
Vaccitech reports 2022 EPS 14c vs. ($1.96) last year
PremiumThe Fly
Vaccitech reports 2022 EPS 14c vs. ($1.96) last year
1y ago
VACC
Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
PremiumPress Releases
Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
1y ago
VACC
Vaccitech announces interim data from Phase 1b/2 trial of VTP-200
PremiumThe FlyVaccitech announces interim data from Phase 1b/2 trial of VTP-200
1y ago
VACC
Vaccitech appoints Pelletier as Chief Scientific Officer
PremiumThe Fly
Vaccitech appoints Pelletier as Chief Scientific Officer
1y ago
VACC
Vaccitech to hold a KOL webinar
PremiumThe Fly
Vaccitech to hold a KOL webinar
1y ago
VACC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >